UV analyses determined several significant factors contributing to survival: ECOG PS, serum albumin, AFP levels, switching to sorafenib, advanced stage BCLC C, liver dysfunction (CTP C), tumor progression, and disease progression. This evidence concerns the gene ALB and neoplasm.